BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 19280552)

  • 1. Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma?
    Ricci P; Cantisani V; Drudi F; Pagliara E; Bezzi M; Meloni F; Calliada F; Erturk SM; D'Andrea V; D'Ambrosio U; Passariello R
    Ultraschall Med; 2009 Jun; 30(3):252-8. PubMed ID: 19280552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.
    Wiggermann P; Brünn K; Rennert J; Loss M; Wobser H; Schreyer AG; Stroszczynski C; Jung EM
    Ultraschall Med; 2013 Dec; 34(6):590-4. PubMed ID: 24132649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
    Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
    J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
    Du J; Li HL; Zhai B; Chang S; Li FH
    Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma?
    Vilana R; Bianchi L; Varela M; Nicolau C; Sánchez M; Ayuso C; García M; Sala M; Llovet JM; Bruix J; Bru C;
    Eur Radiol; 2006 Nov; 16(11):2454-62. PubMed ID: 16710666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
    Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
    Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound.
    Liu F; Yu X; Liang P; Cheng Z; Han Z; Dong B
    Int J Hyperthermia; 2011; 27(6):555-62. PubMed ID: 21797695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
    Minami Y; Kitai S; Kudo M
    Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance.
    Giorgio A; Ferraioli G; Tarantino L; de Stefano G; Scala V; Scarano F; Coppola C; Del Viscovo L
    AJR Am J Roentgenol; 2004 Nov; 183(5):1319-26. PubMed ID: 15505297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
    Dill-Macky MJ; Asch M; Burns P; Wilson S
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.
    Frieser M; Kiesel J; Lindner A; Bernatik T; Haensler JM; Janka R; Hahn EG; Strobel D
    Ultraschall Med; 2011 Apr; 32(2):148-53. PubMed ID: 21225567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
    Jung EM; Clevert DA; Rupp N
    Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
    Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
    Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K
    Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.